These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34969660)

  • 41. The potential role of the gut microbiota in shaping host energetics and metabolic rate.
    Lindsay EC; Metcalfe NB; Llewellyn MS
    J Anim Ecol; 2020 Nov; 89(11):2415-2426. PubMed ID: 32858775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of gut microbiota in the pharmacokinetics of antihypertensive drugs.
    Choi MS; Yu JS; Yoo HH; Kim DH
    Pharmacol Res; 2018 Apr; 130():164-171. PubMed ID: 29391236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome.
    Enright EF; Gahan CG; Joyce SA; Griffin BT
    Yale J Biol Med; 2016 Sep; 89(3):375-382. PubMed ID: 27698621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut microbiome interactions with drug metabolism, efficacy, and toxicity.
    Wilson ID; Nicholson JK
    Transl Res; 2017 Jan; 179():204-222. PubMed ID: 27591027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bacteriophage: A Useful Tool for Studying Gut Bacteria Function of Housefly Larvae, Musca domestica.
    Zhang X; Wang S; Li T; Zhang Q; Zhang R; Zhang Z
    Microbiol Spectr; 2021 Sep; 9(1):e0059921. PubMed ID: 34378967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucose alters the symbiotic relationships between gut microbiota and host physiology.
    Anhê FF; Barra NG; Schertzer JD
    Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E111-E116. PubMed ID: 31794261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dissecting the human gut microbiome to better decipher drug liability: A once-forgotten organ takes center stage.
    Cai J; Auster A; Cho S; Lai Z
    J Adv Res; 2023 Oct; 52():171-201. PubMed ID: 37419381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Connecting the dots: Targeting the microbiome in drug toxicity.
    Luo Y; Zhou T
    Med Res Rev; 2022 Jan; 42(1):83-111. PubMed ID: 33856076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multi-omics Approaches To Decipher the Impact of Diet and Host Physiology on the Mammalian Gut Microbiome.
    Milani C; Alessandri G; Mancabelli L; Mangifesta M; Lugli GA; Viappiani A; Longhi G; Anzalone R; Duranti S; Turroni F; Ossiprandi MC; van Sinderen D; Ventura M
    Appl Environ Microbiol; 2020 Nov; 86(23):. PubMed ID: 32948523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drugging the gut microbiota: toward rational modulation of bacterial composition in the gut.
    Altamura F; Maurice CF; Castagner B
    Curr Opin Chem Biol; 2020 Jun; 56():10-15. PubMed ID: 31678829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect?
    Doré J; Multon MC; Béhier JM;
    Therapie; 2017 Feb; 72(1):21-38. PubMed ID: 28131442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bringing microbiome-drug interaction research into the clinic.
    Guthrie L; Kelly L
    EBioMedicine; 2019 Jun; 44():708-715. PubMed ID: 31151933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An Insight into Diversity and Functionalities of Gut Microbiota in Insects.
    Wang S; Wang L; Fan X; Yu C; Feng L; Yi L
    Curr Microbiol; 2020 Sep; 77(9):1976-1986. PubMed ID: 32535651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Host Species and Geography Differentiate Honeybee Gut Bacterial Communities by Changing the Relative Contribution of Community Assembly Processes.
    Ge Y; Jing Z; Diao Q; He JZ; Liu YJ
    mBio; 2021 Jun; 12(3):e0075121. PubMed ID: 34061602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gut microbiota functions: metabolism of nutrients and other food components.
    Rowland I; Gibson G; Heinken A; Scott K; Swann J; Thiele I; Tuohy K
    Eur J Nutr; 2018 Feb; 57(1):1-24. PubMed ID: 28393285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility.
    Enright EF; Joyce SA; Gahan CG; Griffin BT
    Mol Pharm; 2017 Apr; 14(4):1251-1263. PubMed ID: 28186768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine.
    Khalsa J; Duffy LC; Riscuta G; Starke-Reed P; Hubbard VS
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):176-185. PubMed ID: 28263462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Microbial Community Cultured in Gradient Hydrogel for Investigating Gut Microbiome-Drug Interaction and Guiding Therapeutic Decisions.
    Zheng DW; Qiao JY; Ma JC; An JX; Yang CH; Zhang Y; Cheng Q; Rao ZY; Zeng SM; Wang L; Zhang XZ
    Adv Mater; 2023 Jun; 35(22):e2300977. PubMed ID: 37029611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kansuiphorin C and Kansuinin A ameliorate malignant ascites by modulating gut microbiota and related metabolic functions.
    Zhang Y; Lou JW; Kang A; Zhang Q; Zhou SK; Bao BH; Cao YD; Yao WF; Tang YP; Zhang L
    J Ethnopharmacol; 2020 Mar; 249():112423. PubMed ID: 31765764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.